FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease

Alcon says its newest dry eye drug can show improved tear production as early as day 1 of therapy, overcoming a key complaint about some interventions that require a ramp-up period. Photo: Alcon. Click image to enlarge. Topical dry eye therapy, initially dominated by immunomodulators for over 20 years, has begun to diversify in recent years, with steroids and lip